|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,415.95 INR | -1.93% |
|
+2.42% | -2.23% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 36.6x | 15.69x | 3.64x | - | - | - | 1.2% | 4.39B | ||
| 34.84x | 20.98x | 0.71x | 12.66x | 25.79x | 26.58x | 0.57% | 1,063B | ||
| 27.14x | 6.83x | -1.79x | 6.24x | 16.98x | 18.73x | 2.1% | 611B | ||
| 30.97x | 961.36x | 0.13x | 7.43x | 15.19x | 15.59x | 2.76% | 444B | ||
| 17.52x | 6.51x | 1.03x | 4.36x | 10.71x | 12.08x | 3.05% | 324B | ||
| 22.92x | 5.38x | 1.01x | 4.81x | 13.47x | 14.35x | 1.81% | 285B | ||
| 21.57x | 6.45x | -40.77x | 5.54x | 13.39x | 14.67x | 2.85% | 283B | ||
| 14.31x | 6.28x | -8.32x | 5.31x | 10.9x | 12.79x | 3.5% | 219B | ||
| 23.55x | 17.94x | 3.01x | 6.27x | 11.03x | 14.35x | 2.79% | 195B | ||
| -44.98x | 7.99x | 0.32x | 5.45x | 30.27x | 60.81x | 2.58% | 156B | ||
| 11.17x | 1.55x | 0.2x | 2.99x | 7.28x | 8.47x | 7.34% | 136B | ||
| 28.48x | 5.71x | 2.01x | 8.71x | 19.65x | 20.46x | -.--% | 126B | ||
| 11.2x | 4.97x | 0.25x | 3.04x | 8.13x | 8.84x | 4.45% | 115B | ||
| 12.36x | 4.47x | 1.16x | 2.7x | 7.92x | 8.95x | 3.63% | 102B | ||
| 10.87x | 1.17x | 2.16x | 2.08x | 6.74x | 7.65x | 5.83% | 99.86B | ||
| 23.54x | 5.34x | 1.36x | 7.97x | 15.08x | 15.77x | 1.88% | 73.78B | ||
| 20.83x | 1.71x | -0.13x | 1.75x | 8.32x | 13.96x | 0.47% | 54.83B | ||
| 38.23x | 5.17x | 1.99x | 8.6x | 28.68x | 29.63x | 0.51% | 52.27B | ||
| 41.87x | 1.11x | 51.19x | 2.6x | 9.54x | 26.44x | 3.97% | 50.1B | ||
| 18.21x | 1.82x | 4.52x | 3.32x | 12.46x | 13.99x | 2.28% | 41.03B | ||
| Average | 20.06x | 54.42x | 1.18x | 5.36x | 14.29x | 18.11x | 2.68% | 221.84B | |
| Weighted average by Cap. | 23.22x | 105.38x | -1.98x | 7.20x | 16.89x | 19.33x | 2.27% |
- Stock Market
- Stocks
- GLAXO Stock
- Sector GlaxoSmithKline Pharmaceuticals Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















